Sarda Proteins Ltd Share Price

10.40

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 24-Aug-2019 - -
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2019 ,inter alia, to consider and approve 1 To consider and approve the re-appointment of M/s. Khetawat Agarwal & Co., Chartered Accountants as Statutory Auditor of the Company, subject to the approval of members at the ensuing AGM; 2 To consider and approve appointment of Mr. Rupesh Tambi as Independent Director of the company subject to approval of shareholders; 3 To consider and approve appointment of Mrs. Vanita Bhanot as Director (Non-Executive) of the company subject to approval of shareholders; 4 To consider and approve appointment of Mr. Deepak Data as Managing Director of the company subject to approval of shareholders; 5 To consider and approve appointment of Mr. Tarun Kumar Taunk as Independent Director of the company subject to approval of shareholders; 6 To consider and approve day,date,time,place and notice of the 28th AGM of the Company; 7 To consider and approve Boards Report of the company for the FY 2018-19; 8 To finalize the dates of Book Closure and E- voting for 28th AGM of the company. Outcome of the Board Meeting held on Monday, 02nd September, 2019 and Disclosures pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) (As Per BSE Announcement Dated on 02.09.2019)
Board Meeting - 03-Aug-2019 - -
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 12th August, 2019 at 04:00 P.M. at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) inter alia to approve the Un-audited Financial Results of the company for the Quarter ended on 30th June, 2019 and to take on record the Limited Review Report thereon. Outcome of Board Meeting (As Per BSE Announcement Dated 12.08.2019)
Board Meeting - 17-May-2019 - -
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2019 ,inter alia, to consider and approve the Audited Financial Results of the company for the quarter and year ended on 31st March, 2019 along with Statement of Assets and Liabilities as on March 31, 2019 and to take on record the Auditors Report thereon. Further, in continuation to our disclosure on Closure of Trading Window dated 04th April, 2019 pursuant to the provision of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended and the Companys Code of Conduct to regulate, monitor and report trading by Designated Persons please be informed that the trading window for trading in securities of the company shall remain closed for all Designated Persons (as defined in the Code) till Wednesday, 29th May, 2019 (both days inclusive). Outcome of Board meeting held on 27.05.2019 to approved the Audited financial results for the quarter and year ended on 31st March, 2019 along with Statement of Assets and Liabilities as on March 31, 2019 the Auditors Report thereon Audited Financial Results of the company for the quarter and year ended on 31st March, 2019 along with Statement of Assets and Liabilities as on March 31, 2019 and auditors report thereon. (As Per BSE Announcement Dated 27.05.2019)
Board Meeting - 28-Jan-2019 - -
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2019 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that 05/2018-19 meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 05th February, 2019 at 04:00 P.M. at the registered office of the Company situated at G-1-177(A), Matsya Industrial Area, Alwar-301030 (Rajasthan) inter alia to approve the Un-audited Financial Results of the company for the quarter and nine months ended 31st December, 2018 and to take on record the Limited Review Report thereon. We hereby intimate that 05/2018-19 meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 05th February, 2019 at 04:00 P.M. at the registered office of the Company situated at G-1-177(A), Matsya Industrial Area, Alwar-301030 (Rajasthan) inter alia to approve the Un-audited Financial Results of the company for the quarter and nine months ended 31st December, 2018 and to take on record the Limited Review Report thereon. Further, in terms of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Companys Code of Conduct for Prohibition of Insider Trading, the Trading Window for trading in the shares of the Company shall remain closed for all Designated Persons (as defined in the Code) from Monday, 28th January, 2019 to Thursday, 7th February, 2019 (both days inclusive). You are requested to kindly take the same on record and inform all those concerned accordingly. Un-audited financial results for the quarter and nine months ended 31st December, 2018 alongwith limited review report on the un-audited financial results of the company. (As Per BSE Announcement Dated on 05/02/2019)
Board Meeting - 02-Nov-2018 - -
SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2018 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that 04/2018-19 meeting of the Board of Directors of the Company is scheduled to be held on Monday, 12th November, 2018 at 04:00 P.M. at the registered office of the Company situated at G-1-177(A), Matsya Industrial Area, Alwar-301030 (Rajasthan) inter alia to approve the Un-audited Financial Results of the company for the quarter and half year ended 30th September, 2018 along with statement of assets and liabilities as on and to take on record the Limited Review Report thereon . Un-audited Financial Results of the company for the quarter and half year ended 30th September, 2018 along with Statement of Assets and Liabilities as on 30th September, 2018 and Limited review report on the Un-audited Financial Results of the company. The Board of Directors of the Company in their meeting held on Monday, the 12th day of November, 2018, which commenced at 04:00 P.M. and concluded at 05:00 P.M., at the registered office of the Company situated at G-1-177(A), Matsya Industrial Area, Alwar-301030 (Rajasthan) inter-alia, transacted the following business: 1. Approved the un-audited financial results for the quarter and half year ended 30th September, 2018 along with Statement of Assets and Liabilities as on 30th September, 2018. Further, the extract of result would also be published in the newspaper in compliance with regulation 47 of Listing Regulations. 2. Took on record the Limited review report on the Un-audited Financial Results for the quarter and half year ended 30th September, 2018. 3. Took on record the statement of Investor Grievances pursuant to Regulation 13 of Listing Regulations, stating that no complaints from the investors have been received during the quarter ended on September 30, 2018. (As Per BSE Announcement Dated On 12/11/2018)